The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Gemcitibine (G) and docetaxel (D) in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy.
Emanuela Palmerini
No relevant relationships to disclose
Robin Lewis Jones
No relevant relationships to disclose
Anna Paioli
No relevant relationships to disclose
Emanuela Marchesi
No relevant relationships to disclose
Cristina Piera Meazza
No relevant relationships to disclose
Luca Coccoli
No relevant relationships to disclose
Seth Pollack
No relevant relationships to disclose
Piero Picci
No relevant relationships to disclose
Angela Tamburini
No relevant relationships to disclose
Marilena Cesari
No relevant relationships to disclose
Eric L. Staals
No relevant relationships to disclose
Stefano Ferrari
No relevant relationships to disclose